Table I.
Baseline characteristics
| Parameter | Study population | Synergy | Control | P-value |
|---|---|---|---|---|
| Study population, N | 814 | 407 | 407 | |
| Male, n (%) | 618 (75.9) | 305 (74.9) | 313 (76.9) | 0.51 |
| Age, median (IQR) [years] | 72 (62–78) | 71 (62–78) | 72 (62–78) | 0.97 |
| Previous CABG, n (%) | 121 (14.9) | 74 (18.2) | 47 (11.5) | < 0.01 |
| Procedure indication, n (%): | ||||
| STEMI | 123 (15.1) | 45 (11.1) | 78 (19.2) | < 0.01 |
| NSTE-ACS | 335 (41.2) | 205 (50.4) | 130 (31.9) | |
| Stable CAD | 356 (43.7) | 157 (38.6) | 199 (48.9) |
CABG – coronary artery bypass grafting, CAD – coronary artery disease, IQR – interquartile range, NSTE-ACS – non-ST-elevation acute coronary syndrome, STEMI – ST-elevation myocardial infarction.